NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the OTC Report

May 18, 2012 11:30:00 AM

NEW YORK, NY — (Marketwire) — 05/18/12 –   This is an investment opinion on Facebook (NASDAQ: FB), Yippy, Inc. (PINKSHEETS: YIPI), Microsoft(NASDAQ: MSFT) and Google (NASDAQ: GOOG). In a New York Times article yesterday highlighting theFacebook (NASDAQ: FB) IPO, it is speculated thatFacebook “will not be able to ignore the huge search advertising market for long and will be drawn into creating a search engine that more directly competes with Google(NASDAQ: GOOG).”

The article continues with, “As the rivalry between Facebook and Google intensifies, Microsoft (NASDAQ: MSFT) has chosen to get steadily cozier with Facebook. Facebook and Microsoft are collaborating on Internet search, employing the gobs of user data generated by members of the social network to improve searches on Microsoft’s Bing.” Forbes also had an article stating that they expect Facebook to move into search. WhetherFacebookchooses to do it in-house or through acquisition remains to be seen.

Yippy.com (PINKSHEETS: YIPI), a new economy technology company that develops advanced search technologies, content aggregation services and application services has also made headlines with the addition of two new board members, Morton Fink, who was previously the CEO of Warner Home Video and a Senior Vice President of Sony Corporation of America and Debbie Sharken who is currently Chief Marketing Officer at theDirect Marketing Association.

According to a Market Access Profile from Standard & Poor’s one of the principal stockholders of Yippy, Inc., Vivisimo, Inc., was recently acquired by IBM for an undisclosed amount. (http://reports.standardandpoors.com/aidata/maccess/pdf/98584y20.pdf)

This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Information, opinions and analysis contained herein are based on sources deemed to be reliable and are subject to change without notice. A third party has hired and paid OTC Report one thousand two hundred and ninety five dollars for the publication and circulation of this news release. Accordingly, certain information included herein may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. However, no representation, expressed or implied, is made as to the accuracy, completeness or correctness. In light of the above, we accept no liability for any losses arising from an investor’s reliance on or use of this report. We do not and have not had any ownership interest in said third party of any kind.

Source: OTC Report

DISCLAIMER: This email and the content provided is intended for advertisement purposes only. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our e-mail list. PLEASE NOTE: NorthStarStocks employees/affiliates are not registered as an Investment Advisor in any jurisdiction whatsoever. Release of Liability: Through use of this website/newsletter viewing or using you agree to hold NorthStarStocks, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources, which we believe to be reliable, but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. NorthStarStocks.com’s affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. NorthStarStocks.com encourages readers and investors to supplement the information in these reports with independent research and other pro advice. All information on featured companies is provided by the companies profiled, or is available from public sources and NorthStarStocks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. NorthStarStocks.com often receives compensation for marketing, awareness and investor relation services, which can be reviewed within each particular newsletter/profile and our disclaimer. NorthstarStocks.com has previously been compensated twenty-five thousand dollars directly from Yippy Inc. in 2011.  NorthStarStocks.com has currently been compensated ten thousand dollars directly from the company Yippy Inc. for the distribution of this email and other marketing services for one week(expired). We may or may not hold a position and reserve the right to buy or sell shares at any time, which may positively or negatively affect the price per share. This profile is not a solicitation to buy or sell any securities. NorthStarStocks nor any of its affiliates are registered investment advisers or broker dealers. View our entire Disclaimer Here.

Fireman’s Contractors, Inc. (OTCQB: FRCN) (OTC BB: FRCN) is a full reporting Commercial Contractors that provides professional services to commercial and government clients in the areas of Road Improvements, Pavement Maintenance, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, and ADA Compliance. Fireman’s Contractors has completed its FDD requirements with the Federal Trade Commission and has developed franchise territories across the U.S. The Company’s goal is to develop 300 of new franchise locations in the next 24 to 48 months. Fireman’s Contractors brings a professional value system delivering outstanding results through honorable customer relationships and repeat business. Local firefighters are supported by a portion of profits which are donated to local Firefighter Associations. For more information on the company, visit www.FiremansContractors.com.

Firemans Contractors is committed to providing superior service in parking lot maintenance and construction services. Our services include Road Improvements, Paving, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, ADA Compliance, Pressure Washing and other construction services. With Firemans Contractors you get a quality experience at a competitive price. Founded by a Fireman, our values reflect that of Firefighter’s – which motivate us to achieve outstanding results as we deal honorably with our customers, communities and each other. We support firefighters for safer communities by giving a portion of our profits to local fire fighter associations. Call us first for fast and reliable service.

Contractors You Can Trust ®

Firemans Contractors is committed to providing superior road and parking lot maintenance services.

Mission Statement Fireman’s Contractors is committed to providing superior service in painting, seal coating, parking lot striping, and construction services with quality you can count on. With Fireman’s Contractors you get a quality experience at a competitive price. Our values reflect that of Firefighter’s – which motivate us to achieve outstanding results as we deal honorably with our customers, communities and each other. We support firefighters for safer communities by giving a portion of our profits to local fire departments.

Our Values Fireman’s Contractors, you’ll never be surprised, and we deliver what we promise. You can be assured that we will always deliver superior service that is on time and on budget. We are a company with respect. We respect our employees. We respect our customers. We take personal pride in all of our work. We always have a continuous strive for improvement. We believe there is always room to improve how we work, how we communicate with our customers, and how we build relationships.

Community Outreach We support our Communities Founded by a Fireman, our values reflect that of Firefighter’s – which motivate us to achieve outstanding results as we deal honorably with our customers, communities and each other. We support firefighters for safer communities by giving a portion of our profits to local fire departments. Call us first for fast and reliable service. Firemans Contractors donates 1% to the community on behalf of the client on the Bid Agreement. We take care of the paperwork for you. You, as the client, receive the tax deductible donation benefit while helping your local community.

Recent Company News:

April 10, 2012

• U.S. Chamber of Commerce to Recognize Fireman’s Contractors at 2012 America’s Small Business Summit

April 3, 2012

• Fireman’s Contractors, Inc. Completes More Than $46,000 in New Business; Hosts Discovery Days for Potential Franchisees

March 28, 2012

• Fireman’s Contractors, Inc. Completes $38,000 Project; Builds New Business Relationships at 2012 AAGD Tradeshow

March 22, 2012

• Fireman’s Contractors, Inc. Completes $48,000 Project for Texas Location of International Bank

March 6, 2012

• Fireman’s Contractors, Inc. Recognized as Top 25 Free Enterprise Honoree by U.S. Chamber of Commerce

See the full profile here: http://www.northstarstocks.com/featured-profiles/otcfrcn-firemans-contractors-inc/

Northstarstocks.com expects to receive up to $5,000 cash via bank wire for one day Featured Profile and advertising services for Fireman’s Contractors Inc. OTC:FRCN from a 3rd party.

http://www.northstarstocks.com/disclaimer/

Firemans Contractors is committed to providing superior service in parking lot maintenance and construction services. Our services include Road Improvements, Paving, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, ADA Compliance, Pressure Washing and other construction services. With Firemans Contractors you get a quality experience at a competitive price. Founded by a Fireman, our values reflect that of Firefighter’s – which motivate us to achieve outstanding results as we deal honorably with our customers, communities and each other. We support firefighters for safer communities by giving a portion of our profits to local fire fighter associations. Call us first for fast and reliable service.

Fireman’s Contractors, Inc. (OTCQB: FRCN) (OTC BB: FRCN) is a full reporting Commercial Contractors that provides professional services to commercial and government clients in the areas of Road Improvements, Pavement Maintenance, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, and ADA Compliance. Fireman’s Contractors has completed its FDD requirements with the Federal Trade Commission and has developed franchise territories across the U.S. The Company’s goal is to develop 300 of new franchise locations in the next 24 to 48 months. Fireman’s Contractors brings a professional value system delivering outstanding results through honorable customer relationships and repeat business. Local firefighters are supported by a portion of profits which are donated to local Firefighter Associations. For more information on the company, visit www.FiremansContractors.com.

Firemans Contractors Corporate  Headquarters

2406 Gravel Dr. Fort Worth, TX 76118
Tel: 1(800) 475-147

For All Investors

Website: www.HalliburitonIR.com
Phone: 972-458-8000

Mission Statement

Fireman’s Contractors is committed to providing superior service in painting, seal coating, parking lot striping, and construction services with quality you can count on. With Fireman’s Contractors you get a quality experience at a competitive price. Our values reflect that of Firefighter’s – which motivate us to achieve outstanding results as we deal honorably with our customers, communities and each other. We support firefighters for safer communities by giving a portion of our profits to local fire departments.

Firemans Contractors – Contractors You Can Trust ® Call: 800.475.1479  

Our Values

Fireman’s Contractors, you’ll never be surprised, and we deliver what we promise. You can be assured that we will always deliver superior service that is on time and on budget. We are a company with respect. We respect our employees. We respect our customers. We take personal pride in all of our work. We always have a continuous strive for improvement. We believe there is always room to improve how we work, how we communicate with our customers, and how we build relationships.

Insured

At Fireman’s Contractors, we carry a general liability of $2,000,000 with Ohio Casualty and carry workman’s compensation insurance as well.

One Year Limited Warranty

One year from the date the job is finished, Fireman’s Contractors warrants against defective workmanship. The following items are not warranted: caulk, horizontal surfaces, galvanized metal, any items dust, mildew, or exterior moisture damage.

Click here to view the embedded video.

Northstarstocks.com expects to receive up to $5,000 cash via bank wire for one day Featured Profile and advertising services for Fireman’s Contractors Inc. OTC:FRCN from a 3rd party.

http://www.northstarstocks.com/disclaimer/

Drake Gold Resources, Inc.

OTC : DKGR

Email: IR@DrakeGold.com
Investor Relations: 530-405-3547
311 Division Street Carson City, Nevada 89703

Drake Gold Resources, Inc. (DKGR) is a property development holding company focusing on developing investments through acquisitions on income producing properties in various sectors including real estate, petroleum and precious metal mining.

CORPORATE OBJECTIVE

Objective 1 – Corporate Organization

1. Launch of Corporate website & blog – COMPLETE
2. Start Company newsletter – COMPLETE
3. Settle share accruals and outstanding obligation to better prepare the company for acquisitions & developments – COMPLETE
4. Settle debts on balance sheet to better prepare the company for acquisitions & developments – COMPLETE
5. Official appointment of Management – COMPLETE
6. Release current financial statements and post to corporate website – COMPLETE
7. Release OTC Markets disclosure statement with financial statements to OTC Markets to obtain Current Information status – COMPLETE

Objective 2 – Business Development

1. Introduce Financing Partner – PENDING
2. Release first addition to corporate portfolio
3. Release letters of intent on new acquisitions
4. Release new acquisitions for corporate portfolio

The above working outline does not represent a time line or order of completion and is subject to change. Updates will continue to be made as developments reach points of completion.

CORPORATE PROTOCOL

All news announcements / updates shall be made to the Company’s website / newsletter first.

Filings / updates will be made to the Company’s website / newsletter and through OTC Markets website as definitive agreements are materialized.

Letters of Intent shall only be posted to the Company’s website / newsletter.

CORPORATE PORTFOLIO

OIL & GAS

Drake intends to focus on domestic, mature oil fields which eliminate the exploration risks whilst recognizing the preferred investment criteria of investors and funding groups. The use of enhanced oil recovery (“EOR”) technologies includes surfactant/fracturing stimulation, surfactant-polymer technology, and water flooding methods.

The company has targeted the acquisition of 300 wells in the Appalachian Basin. This targeted region has over 15,000 marginal or non-producing wells due to the following:

Neglect;

Small, independent owners lacking resources

Financial inability of owners to invest in rehabilitation;

Lack of access or knowledge of new technologies;

Desire to exit given current market price of oil;

Other reasons specific to each lease.

The company intends to initially secure options for wells on a number of properties in Venango County, PA, and then expand to other regions of the US based on the amount of funding available, cash flows generated, and value of the leases. Research indicates that secondary oil has never been recovered in the Venango Sandstone Formation. Hence, our  longer term strategy will be to reinvest the majority of cash flows that are generated.

Estimates have the proven secondary oil reserves at approximately 330 million barrels (1 Million Barrels = 1 MMbls) of oil in the Appalachian Basin Reservoir, based on a report by the US Department of Energy, with OOIP (Original Oil in Place) remaining reserves exceeding 60 billion barrels.

Drake’s continuing operating strategy will be to seek out, evaluate and acquire interests in those oil and gas projects that in the opinion of management fit the following criteria:

Proven producing oil and gas reserves with substantial development potential;

Proven reserves that can be activated with appropriate financing;

Low-risk drilling and development costs;

Good access to infrastructure to bring to market;

Ability to generate profits and cash flows in a short period of time;

Potential as highly undervalued assets.

REAL ESTATE

Drake intends engage in community based real estate development focusing on social, environmental, and economic sustainability with the maximization of profits

Zoning is RH (High Density Residential) which is a high density multi-dwelling zone. Density is not regulated by a maximum number of units per acre. Rather, the maximum size of buildings and intensity of use is regulated by floor area ratio (FAR) limits and other site development standard. Generally, the density will range from 80 to 125 units per acre. Allowed housing is characterized by medium to high and a relatively high percentage of building coverage. Generally, RH Zones will be well served by transit facilities or be near areas supportive of commercial services.

Subject properties must include access to public transportation services. Targeted areas receive a significant share of the city’s growth as future developments will transform the areas surrounding into a mixed-use areas of retail, office, and housing with a correspondingly high level of pedestrian amenities.

As an example, developers may utilize the Transit Oriented Development (TOD) Property Tax Exemption through the Portland Development Commission (PDC). The TOD is a ten-year property tax exemption established to support both high density housing and Mixed-Use developments that are affordable to a broad range of the general public along vacant or underutilized sites along transit corridors where design and features encourage building occupants to use public transit.

Drake has been managing an investment with a real estate development company since August 2009. At this time Drake intends to wind up, dissolve or otherwise terminate agreements it has with this company to prepare for the new acquisition targets. Details will be released via OTC Market filings once material agreements have been finalized.

PRECIOUS METAL MINING

Drake intends to engage in exploration, development, mining, processing, property acquisition, marketing of products, small-scale mining operations and revitalization of old and abandoned mining properties into profitable business in collaboration with joint venture partners.

Drake’s vision and mission for the development of the mining industry is to partner with joint venture partners in order to acquire abandoned mines with proven reserves that may have been left for centuries. Similarly, it will develop an environmentally friendly and sustainable operation adopting the best mining practices projecting low Capital Cost projects yet income generating business with optimization in the extraction of valuable minerals while at the same time aiming to provide community enrichment by strengthening local governance and enhancement of the living standards of the employee and community as a whole bringing sustainable economic growth.

Drake intends to acquire land leases on properties known to have gold deposits. The business will then develop gold mines on these properties with the intent to extract, smelt, and package the gold into bars for sale onto the open market. The initial capital sought in this business plan will allow the business to acquire its first land lease while concurrently sourcing the equipment needed to operate a moderate sized gold mining operation.

Mining and quarrying of gold is a $3 billion dollar a year business in the United States. Within the industry there are over 200 domestic providers of gold mining operations that operate within 20 states. The industry employs more than 10,000 people and provides adjusted annualized payrolls in excess of $500,000,000 dollars. The growth rate of this industry has been tremendous with the recent resurgence of inflation. The prices of gold (and other precious metals) have increased substantially as investors have sought the safe haven of commodities in lieu of the falling value of the dollar in addition to the global economic risks. Additionally, the greater wealth of developing nations has pushed the per ounce price of gold passed $800. This demand is expected to remain strong in the face of inflationary pressures

SHARE STRUCTURE INFO As of 12/31/2011

A/S : 950,000,000 shares

O/S : 663,743,820 shares

FLOAT :  362,238,866 shares

CORPORATE NEWS

 Real Resource Fund Intends to Invest $1,000,000 Into Drake Gold Resources’ Oil & Gas Work Program – April 4 2012
Drake Gold Resources Provides Update On Its Financing Partner and Its First Acquisition – March 22 2012
Drake Gold Resources Obtains OTC Pink Current Information Tier Status and Schedules CEO Interview – March 14 2012
Drake Gold Resources Provides Corporate Update: OTC Markets Filings, Financing Partner, CEO Interview – March 5 2012
Drake Gold Resources Announces Release Of Financial And Disclosure Statements
Drake Gold Resources Appoints Chief Executive, Operating and Financial Officers
Drake Gold Resources Announces the Appointment of New Management
Drake Gold Resources Launches Business Plan For 2012

Northstarstocks.com expects to receive up to $5,000 cash via bank wire for one day Featured Profile and advertising services for Drake Gold Resources OTC:DKGR from a 3rd party.

http://www.northstarstocks.com/disclaimer/

 

Proteonomix Inc. [OTC:PROT]

Proteonomix is a biotechnology company focused on developing therapeutics based upon use of human cells and their derivatives. The Proteonomix Family of companies includes Proteoderm, StromaCel, National Stem Cell, PRTMI, The Sperm Bank of New York and THOR BioPharma. Proteoderm, Inc. is wholly owned subsidiary that has developed an anti-aging line of skin care products. StromaCel, Inc. develops therapeutic modalities for the treatment of Cardiovascular Disease (CVD). National Stem Cell, Inc. is Proteonomix’s subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. (“PRTMI”) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies.

The Proteonomix Mission

Their mission is to focus upon the development of therapies based upon the use of human stem cells and their derivatives, particularly in the areas of diabetes and cardiac diseases. They primarily employ bone marrow, pancreatic, and umbilical cord blood derived cells in a process of identification, separation, expansion and delivery towards treatment of diseases previously considered incurable. It is their further goal to deliver these therapies to the widest possible spectrum of patients both geographically and economically in the minimum time.

Primary Focus

They are primarily focused on developing therapies and products based upon the use of human stem cells and their derivatives with an initial focus on diabetes and cardiac diseases.

Stem cell therapy provides much promise for the treatment of diseases previously regarded as incurable.
Many of the currently incurable diseases associated with aging are caused by the degeneration of specific cell types in the body. These diseases include but are not limited to cancer, heart disease, diabetes, and autoimmune conditions. Stem cell therapy provides much promise for the treatment of diseases previously regarded as incurable.

StromaCel™ Cardiac Treatment
They are developing their Post Myocardial Infarction treatment, StromaCel™. This treatment is taken intravenously in the first 14 days following an infarction to assist to rebuild the underlying vascular tissuein order to increase cardiac muslcle recovery. They are currently seeking funding to make application for FDA Clinical trials on this promising treatment.

Diabetes Research
They have been in research and development for many years on a treatment for all forms of diabetes. Recent breakthroughs in their research have encouraged us to seek funding for large animal trials in anticipation of Phase 1 trials to follow.

Other Areas of Development
Proteonomix also looks at overall health and wellness. As their Proteoderm products comes to market for skin rejuvination and anti-aging, we are also developing additional products to improve the quality of their clients lives.

Management

Michael Cohen

President, Chief Executive Officer, Chairman of the Board

Michael Cohen has served as their President, Chief Executive Officer and Chairman of their board of directors since September 12, 2006. Michael Cohen began his career as a paramedic for NYC EMS in 1989. He joined Americorp Securities as a Vice President in its mergers and acquisitions department in 1994. He was instrumental in launching a number of successful IPOs at Americorp Securities. He was recruited by Dafna Construction in 1995 as its CFO and played a principal role in its growth and subsequent purchase. In 1997, Mr. Cohen joined Citigroup as a Vice President of Corporate Finance and managed a department in the risk management division of Salomon Smith Barney. In 2002, Mr. Cohen founded National Stem Cell Inc, their operating subsidiary. Mr. Cohen serves as our Chairman of the Board and President as well as the Principal Investigator for most of their therapeutic developments. Mr. Cohen attended Skidmore College and graduated with a Bachelor of Science from Haifa University in 1988.

Ian McNiece

Ph.D., Chief Scientific Officer, Director

Dr. McNiece received his PhD in 1986 from the University of Melbourne undertaking his thesis work in studies of blood cell development at the Peter MacCallum Cancer Institute in Melbourne, Australia. He moved to the USA in July of 1986 to the University of Virginia as a postdoctoral fellow. In August 1998 he started working at Amgen Inc, as a Research Scientist and then as a Laboratory Head. In September 1997, he left Amgen and moved to the University of Colorado as the Director of Research in the Bone Marrow Transplant Program. Subsequently, he moved to Johns Hopkins University as a Professor of Oncology and Laboratory Director of the Graft Engineering Laboratory from January 2003 to May 2007. This laboratory is responsible for all processing of bone marrow, peripheral blood progenitor cell (PBPC) products and cord blood products for transplantation of cancer patients. He was actively involved in optimization of cellular grafts for patient treatment and the translation of basic research to clinical treatment. In July, 2007 he joined the Stem Cell Institute at the University of Miami as Director of the Experimental and Clinical Cell-Based Therapies and is presently Professor of Medicine at the University of Miami.

Jason Isaacs

Secretary

Jason Isaacs joined as Secretary in June of 2010. Mr. Isaacs brings over thirteen years of legal experience. Mr. Isaacs is General Counsel of Green Hills Software, Inc., the largest independent provider of real time operating systems and embedded software development tools. Mr. Isaacs has a wide base of legal experience managing and protecting intellectual property resources, negotiating technology transactions with major corporations and governments, and complying with applicable laws and regulations. Mr. Isaacs practiced law at Brobeck Phleger & Harrison LLP and Heller Ehrman LLP in San Diego, specializing in technology transactions, licensing arrangements and business litigation in his representation of high growth and venture backed companies. Mr. Isaacs received his law degree from Harvard Law School, cum laude, and a B.A. from Brown University, magna cum laude, Phi Beta Kappa.

Steven Byle

Director

Steven Byle joined their board of directors on January 5, 2009. Mr. Byle brings twenty years of experience in technology development and corporate management in the international market.  Mr. Byle is a successful entrepreneur, engineer, and patent attorney for a diverse array of international, public and private, ventures. Mr. Byle is presently the Vice President of Technology for Dockwise, a public energy services company on the Euronext Amsterdam exchange (DOCKW:NA) with annual revenues exceeding US $500 million.  Mr. Byle is also a founder and Member of the Board for a diverse group of companies, including: Pantheon Energy, an alternative energy company in Europe, Core International Group, a Cyprus company performing international manufacturing, logistics and distribution with plants in India and Malaysia, and Texas Auto Superstore, an online auto dealer in the United States. Mr. Byle speaks Spanish and Mandarin Chinese fluently, holds a J.D. degree with Honors in law from the University of Texas School of Law, specializing in Intellectual Property Law, and holds a B.S. degree in Engineering from the University of Michigan, summa cum laude as a prestigious Angell Scholar.

Roger Fidler Esq.

Corporate Council

Mr. Fidler has been engaged in the private practice of law since 1983, specializing in corporate and securities law. Mr. Fidler was the sole director, President, Chief Executive and Financial Officer of Global Agri-Med Technologies, Inc., a corporation that is publicly traded in the pink sheets, since inception in October 28, 1999 until January 11, 2010. Mr. Fidler has previously served on the Boards of Directors and as an officer of several other publicly held corporations, including Diehl Graphsoft, Inc., D-Lanz Development Group, Inc., the Leonard Swindbourne Acquisition Corp., and numerous private companies. Mr. Fidler received a B.S. degree in Physics from Dickinson College, Carlisle, Pennsylvania in 1972; a Masters of Science degree from the University of Illinois at Champaign-Urbana, Illinois in 1974; and a Juris Doctor from the University of South Carolina in 1977 where he was a member of the Law Review. He is a member of the bars of New Jersey, New York and the District of Columbia and has practiced before the federal and state courts in New York and New Jersey as well as pro hac vice in cases before Federal District Courts in Kentucky and Florida. In addition he is a patent attorney authorized to practice before the United States Patent and Trademark Office.

Intellectual Properties and Patent Applications.

Through their operating subsidiary, National Stem Cell, we have developed a catalog of intellectual properties and patent applications. These technologies are designed to work together in a synergistic fashion. Their initial focus in stem cell therapeutics is to achieve a leadership position in:

The Development of Identification Biomarkers
A biomarker is a substance used as an indicator of a biological state which refers to the complete range of genes found in biological structure and processes of the living body, including the nervous system, the endocrine system, and their senses of sight, hearing, taste, smell, and touch. It is a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention) cell derivatives, and cellular proteins.

Expansion Technology
Proteonomix is developing a unique growth medium that allows expansion far beyond the traditional 10:1 achieved in conventional methods before cellular replication errors make it nonviable. This technology is of benefit to any treatment or process that might be improved by drastically increased concentrations or numbers of cells.

Cryopreservation
Proteonomix is developing an innovative cryopreservation technique resulting in substantial reduction in lost cells during the freezing and thawing process. This technology is of benefit where it is advantageous to store cellular material for later use, to maintain stock, or to perform long distance transportation.

Anti-Inflammatory
Proteonomix’s StromaCel™ cellular materials has given some indications as a general anti-inflammatory. We are looking for partners wishing to explore this indication for conditions other than myocardial infarction

Diabetes Research

Cells that they are able to isolate will substantially reduce rejection when transplanted into the liver of the same diabetic patient.
They have identified stem cells in the human pancreas and have applied for patents for cell surface markers (the molecules present on the surface of each cell which define the cell on what receptors are present – a technique often used to associate cells with certain immune functions) for these pancreatic stem cells as well as methods for their isolation.

Based on the fact that these cells are autologous (from same person) rather than from a non-related donor, they anticipate that the cells that they are able to isolate will substantially reduce rejection when transplanted into the liver of the same diabetic patient. The company is performing further research in this area with the University of Miami.

AFFILIATES

Clinical Applications of Regenerative Medicine.
Proteonomix Institutes

Proteonomix is presently forming an international network of Stem Cell Laboratories, following their proprietary Proteonomix Regenerative Translational Medicine Institute (PRTMI) business model.

These institutes focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. The mission of these Institutes is to provide a seamless transition between Proteonomix’s laboratory activities and the local patient care facility. This involves development of clinical protocols, manufacturing of cellular materials for clinical use, monitoring compliance of clinical trials while participating on a global level in these processes.

Distribution of Anti-Aging and Wound Care Products.

Proteoderm Dermatologist
Their subsidiary, Proteoderm is currently forming a network of dermatologist for the distribution of its anti-aging and wound care products.

The networks are expected to activate in the fourth quarter 2010 in the United States and first quarter 2011 in the UAE and regional GCC countries.

For information on becoming a network doctor, or to inquire about starting your own network in a region that is currently not served, please contact us.

Joint Research in Clinical Exploration
Proteonomix’s Technologies

Their technologies have potential efficacy and usefulness in a wide range of applications. They are currently looking for owners of complementary technologies for joint research or affiliates interested in clinical exploration of additional indications for their own technologies.

Expansion Technology: Proteonomix is developing a unique growth medium that allows expansion far beyond the traditional 10:1 achieved in conventional methods before cellular replication errors make it nonviable. This technology is of benefit to any treatment or process that might be improved by drastically increased concentrations or numbers of cells.

Cryopreservation: Proteonomix is developing an innovative cryopreservation technique resulting in substantial reduction in lost cells during the freezing and thawing process. This technology is of benefit where it is advantageous to store cellular material for later use, to maintain stock, or to perform long distance transportation.

Anti-Inflammatory: Proteonomix’s StromaCel™ cellular materials has given some indications as a general anti-inflammatory. They are looking for partners wishing to explore this indication for conditions other than myocardial infarction.

Please read our full Disclaimer here: http://www.northstarstocks.com/disclaimer/
Northstarstocks.com expects to be compensated by a third party for Proteonomix Inc. [OTC:PROT] advertising services.